Kineticos Life Sciences announced today that Thomas A. Pitler, Ph.D. has joined as President and Chief Operating Officer. Dr. Pitler joins Kineticos…
Kineticos takes an immersive stance with their biotech engagements and investments, working closely in a collaborative effort with key leadership roles in…
A mid-size Cell and Gene Therapy biotech is developing AAV based gene therapies for rare diseases. In order to move one of their…
Watch Kineticos’ most recent Biopharma Confidence Index below. Our moderator and panelists discussed the key findings and insights, including a reduction of…
Executives’ confidence in the industry was shaken early in 2020 due to the impact of the COVID-19 pandemic. Yet, this survey (January…
Confidence in the biotechnology industry rebounded after the dip in April 2020 due to the COVID-19 pandemic. Confidence in commercial activities has…
Nathan Finger, Director of Operations and Abe Maingi, Former VP of Precision Medicine, discuss the keys to creating a primary research study…
A conversation with Philip Gialenios, former Chief Commercial Officer, and Nathan Finger, Director of Operations as they talk about the keys to…
What is primary research and why is it important to the life sciences industry? Abe Maingi, former VP of Precision Medicine, discusses…
What is a licensing program and why is it important to the life sciences industry? Nathan Finger, Director of Operations teaches the…
Our December panel discussion is about “Increasing Patient Engagement Through Decentralized Clinical Research.” Our group of expert panelists from Spencer Health Solutions,…
Join the conversation with our panel of Life Sciences industry experts as they discuss the current state of gene editing technologies and…
Join our panel of industry leaders from GeneCentric, Adjuvance Technologies, Locus Biosciences, and Kineticos as they look at Post COVID-19 implications to…
In the first of a set of weekly discussion panels, moderator Philip Gialenios (Kineticos) and panel members Aman Khera (Worldwide Clinical Trials),…
In the second panel discussion, moderator Philip Gialenios (Kineticos) and panel members Aman Khera (Worldwide Clinical Trials), Dan McCormick (Kineticos), Kevin Hampton…
In the third panel discussion, moderator Philip Gialenios (Kineticos) and panel members Peter Benton (Worldwide Clinical Trials), Dan McCormick (Kineticos), Kevin Hampton…
In the fourth panel discussion, moderator Philip Gialenios (Kineticos) and panel members Aman Khera (Worldwide Clinical Trials), Dan McCormick (Kineticos), Kevin Hampton…
In the fifth and final panel discussion, moderator Philip Gialenios (Kineticos) and panel members Aman Khera (Worldwide Clinical Trials), Dan McCormick (Kineticos),…
COVID-19 has been a change agent in four areas of the biopharma industry: digital technology, artificial intelligence (AI) and machine learning, regulation,…
In this two-part survey, Kineticos Life Sciences explores the changes in perceptions and approaches to clinical research over six months (pre-COVID and…